Chimeric Anti-CD14 IGG2/4 Hybrid Antibodies for Therapeutic Intervention in Pig and Human Models of Inflammation-Reference-Cited by-同舟云学术

Chimeric Anti-CD14 IGG2/4 Hybrid Antibodies for Therapeutic Intervention in Pig and Human Models of Inflammation

Published:2013-09-23 Issue:9 Volume:191 Page:4769-4777
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Lau Corinna,Gunnarsen Kristin S.,Høydahl Lene S.,Andersen Jan Terje,Berntzen Gøril,Pharo Anne,Lindstad Julie K.,Ludviksen Judith K.,Brekke Ole-Lars,Barratt-Due Andreas,Nielsen Erik Waage,Stokes Christopher R.,Espevik Terje,Sandlie Inger,Mollnes Tom Eirik

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein

2. Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin

3. Time to abandon dogma: CD14 is expressed by non‐myeloid lineage cells

4. Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects)

5. CD14 Is a pattern recognition receptor

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary miRNA expression after polytrauma depends on the surgical invasiveness and displays an anti-inflammatory pattern by the combined inhibition of C5 and CD14;Frontiers in Immunology;2024-08-29

2. In vitro evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell model;Frontiers in Immunology;2023-04-04

3. Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model;Pediatric Research;2023-02-01

4. Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood;Frontiers in Immunology;2022-12-14

5. Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release;The Journal of Immunology;2022-11-01